Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Galapagos ( (GLPG) ) has provided an update.
On May 27, 2025, Galapagos NV announced the creation of 925,000 subscription rights under a new plan approved by its Board of Directors. This plan, known as ‘Subscription Right Plan 2025 (A)’, is intended for senior management compensation and has an exercise term of eight years with a price of €25.64 per right. The subscription rights, which are not immediately exercisable and will not be listed on any stock market, aim to enhance the company’s operational framework by potentially increasing its share capital and aligning management incentives with shareholder interests.
The most recent analyst rating on (GLPG) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the GLPG Stock Forecast page.
Spark’s Take on GLPG Stock
According to Spark, TipRanks’ AI Analyst, GLPG is a Neutral.
Galapagos’s overall stock score is driven by its financial stability and strong cash reserves, offset by significant profitability and cash flow challenges. Technical indicators show a mildly positive trend, while valuation remains unattractive due to negative earnings. The earnings call highlights strategic initiatives and a robust pipeline, but high restructuring costs and expected cash burn are notable risks.
To see Spark’s full report on GLPG stock, click here.
More about Galapagos
Galapagos is a biotechnology company with operations in Europe, the U.S., and Asia, dedicated to transforming patient outcomes through life-changing science and innovation. The company focuses on high unmet medical needs, leveraging science, technology, and collaborative approaches to create a pipeline of best-in-class medicines. Galapagos is committed to challenging the status quo and delivering results for patients, employees, and shareholders.
Average Trading Volume: 365,181
Technical Sentiment Signal: Sell
Current Market Cap: $1.91B
Find detailed analytics on GLPG stock on TipRanks’ Stock Analysis page.